Irish drug developer secures orphan status for cancer therapy
Priothera looking to improve survival rates of patients with acute myeloid leukaemia
Priothera
Fountain closes third life sciences fund after raising €125m
Group eyeing up to 10 investments, mostly in therapeutics and medical device sectors
Irish leukaemia drug firm Priothera raises €30m to develop therapy
Key players in Dublin-based start-up were involved in successful Inflazome venture
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices